Skip to content
  • Newsletters
  • Events
  • LN
  • Join PMC
  • SR
  • Newsletters
  • Events
  • LN
  • Join PMC
  • SR
Personalized Medicine Coalition Logo
  • About
    • Board of Directors
  • Personalized Medicine 101
  • Policy
    • Public Policy
    • Science Policy
    • Congressional Caucus
  • Research
    • PGx Drug-Gene Associations
    • Disparities in Research
  • Membership
    • Committees & Working Groups
    • Current Members
    • Friends of PMC
    • Member Login
  • News and Resources
    • Leadership Blog
    • Press Releases
    • Multimedia Resources
  • Events
  • Join PMC
  • About
    • Board of Directors
  • Personalized Medicine 101
  • Policy
    • Public Policy
    • Science Policy
    • Congressional Caucus
  • Research
    • PGx Drug-Gene Associations
    • Disparities in Research
  • Membership
    • Committees & Working Groups
    • Current Members
    • Friends of PMC
    • Member Login
  • News and Resources
    • Leadership Blog
    • Press Releases
    • Multimedia Resources
  • Events
  • Join PMC

Policy Category: Public Policy

Personalized medicine benefits patients and may also make the health care system more efficient, but a paradigm shift in medicine will not happen just because the science suggests it should. Policies matter.

With that in mind, the Coalition’s members engage on many public policy topics, including:

Evidence development
Government innovation
Intellectual property
Regulation
Reimbursement
Research funding
Value in health care

FY 2026 Funding Appropriations for NIH

Federal Data Privacy Legislation

FDA Draft Guidance on AI in Regulatory Decision-Making for Drugs and Biologics

FDA Draft Guidance on AI-Enabled Device Software Functions

Encouraging the Continued Development of Personalized Treatments Under the Inflation Reduction Act: PMC Letters of Support for the EPIC, ORPHAN Cures, and MINI Acts

Informing OSTP’s Development of an Artificial Intelligence (AI) Action Plan

FY 2025 Funding Appropriations for NIH

Concerns About AHRQ Review Protocol for Blood-Based Tests for Multiple Cancer Screening

Reducing Administrative Barriers to Accessing Personalized Medicine: Utilization Management Policies in the Medicare Advantage Program

Request for Reconsideration of UnitedHealthcare’s Revised Pharmacogenetic Testing Policy

← older

Blog
Read the latest

Resources
Download publications

Personalized Medicine Coalition
1710 Rhode Island Ave. NW
Suite 700
Washington, DC 20036

202-589-1770
pmc@personalizedmedicinecoalition.org

  • Join PMC
  • SR
  • LN
  • Member Portal
  • Join PMC
  • SR
  • LN
  • Member Portal

© 2025 Personalized Medicine Coalition. All rights reserved. | Privacy Policy